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Abstract
Background: A large and unsuspected tuberculosis outbreak involving 18.7% of the total of the
tuberculosis cases studied, was detected in a population-based molecular epidemiological study
performed in Zaragoza (Spain) from 2001 to 2004.
Methods:  The  Mycobacterium tuberculosis drug-susceptible strain, named MTZ  strain, was
genetically characterized by IS6110-RFLP, Spoligotyping and by MIRU-VNTR typing and the genetic
patterns obtained were compared with those included in international databases. The
characteristics of the affected patients, in an attempt to understand why the MTZ strain was so
highly transmitted among the population were also analyzed.
Results: The genetic profile of the MTZ strain was rare and not widely distributed in our area or
elsewhere. The patients affected did not show any notable risk factor for TB.
Conclusion: The M. tuberculosis strain MTZ, might have particular transmissibility or virulence
properties, and we believe that greater focus should be placed on stopping its widespread
dissemination.
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Background
Mycobacterium tuberculosis is an extremely successful path-
ogen that kills nearly two million people in the world
each year [1]. The study of tuberculosis (TB) epidemiol-
ogy and transmission, traditionally involving patient con-
tact tracing, has been improved by the use of molecular
strain typing [2]. Molecular epidemiological studies have
added much-needed accuracy and precision to the study
of transmission dynamics, and have allowed previously
unresolved issues to be newly addressed, e.g. the classifi-
cation of recent-versus-reactive disease, the extent of exog-
enous reinfection and the detection of unsuspected
transmission events [2].
Advances in molecular typing have led to the identifica-
tion of highly transmissible M. tuberculosis complex
strains in the last years. In New York City, the W strain
caused more than 350 cases [3] and spread to other Amer-
ican states [4]. A Beijing strain imported from Liberia
affected 75 patients in the Gran Canaria Island during the
1990s [5]. Currently, the major threat for TB control is the
transmission of extensively drug-resistant (XDR) strains
[6,7]. However other strains, neither belonging to the W-
Beijing family nor being drug-resistant, have shown exten-
sive dissemination in various countries: the C strain in
New York City [8,9], the CH strain in the UK [10,11], the
Harlingen strain in the Netherlands [12,13] and the Dan-
ish Cluster 1 and 2 strains in Denmark [14].
In Zaragoza (Spain), an unsuspected, extensive transmis-
sion of a drug-susceptible M. tuberculosis strain was
detected during a population-based molecular epidemio-
logical survey from 2001 to 2004 [15]. In this study, 454
M. tuberculosis isolates were analyzed by IS6110-RFLP, and
52.6% were clustered. The largest cluster contained 85 iso-
lates (18.7%); the strain causing this cluster was named
MTZ, Mycobacterium tuberculosis Zaragoza.
The reasons for the dominance and widespread of the
MTZ strain were unclear. The objectives of the present
work were: i) to characterize the MTZ isolates by other
genotyping techniques such as Spoligotyping and MIRU-
VNTR typing, and include it in a Principal Genotype
Group (PGG) ii) to compare the genetic patterns obtained
with those included in international databases and iii) to
analyze the characteristics of the affected patients, in an
attempt to understand why the MTZ strain was so highly
transmitted among the population.
Methods
The  MTZ  cluster was identified in a population-based
study conducted in the province of Zaragoza between 1st
June 2001 and 31st May 2004. A total of 454 M. tuberculo-
sis complex isolates were typed by IS6110-RFLP: 239 iso-
lates were grouped into 45 clusters, each cluster
containing between two and 85 isolates [15].
DNA fingerprinting
IS6110-RFLP
RFLP analysis of the 85 isolates by Southern blotting and
DNA hybridization with IS6110 was performed in the pre-
vious study according to the standard fingerprinting
method [16]. The RFLP pattern was entered into the Span-
ish Database of the University of Zaragoza. This database
includes 5,694 IS6110-RFLP entries from drug-susceptible
and drug-resistant M. tuberculosis complex isolates, 4,637
(81%) of which are from Spanish isolates. The MTZ RFLP
pattern was compared with the other database entries.
Spoligotyping
Spoligotyping was performed according to the method
described by Kamerbeek et al. [17]. The spoligotype
obtained was contrasted with entries contained in the
SpolDB4 database [18]http://www.pasteur-guade
loupe.fr/tb/spoldb4/spoldb4.pdf and was further com-
pared with the updated SITVIT2 database. SITVIT2 is a
proprietary database maintained at the Pasteur Institute of
Guadeloupe, which contains both spoligotype and MIRU-
VNTR patterns of the M. tuberculosis. At the time of this
comparison (30th October 2008), it contained data on
about 70,000 strains from 160 countries of origin.
MIRU-VNTR
The 85 isolates were genotyped by PCR amplification of a
highly discriminatory subset of 15 loci proposed by Sup-
ply et al. [19]. Analyses were performed using five multi-
plex PCRs (Table 1), PCR mixtures and conditions were as
described in reference 19 with some modifications. PCR
products were separated on a 48-capillary MegaBACE™
500 Sequencer (GE Healthcare Life Sciences) using Rox-
labeled MegaBACE ET900-R as a size standard. PCR frag-
ments sizes were determined using the MegaBACE™ Frag-
ment Profiler v1.2 software (GE Healthcare Life Sciences).
VNTR alleles were assigned according to size offsets,
which correct the differences in relative migration
between the size standard and the amplicons. Agarose gel
electrophoresis with PCR products of known size were
used to define size offsets.
Two MTZ isolates were also genotyped by PCR amplifica-
tion of the 12 "old" loci initially described [20], six of
which were also present in the 15 MIRU-VNTR panel and
compared with the updated SITVIT2 database.
The 21 loci analysed were sent to be compared to a web
server, MIRU-VNTRplus [21], that includes a collection of
186 strains representing the major MTBC lineages. For 15
different MIRU-VNTR it was also possible the comparisonBMC Pulmonary Medicine 2009, 9:3 http://www.biomedcentral.com/1471-2466/9/3
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with the patterns included in MLVA database http://mini
satellites.u-psud.fr/MLVAnet/.
Assignation of the MTZ strain to one of the three principal 
genotypic groups
M. tuberculosis MTZ strain was assigned to one of the three
PGG delineated by Sreevatsan et al. [22]. Polymorphism
at codon 463 of the katG  gene was evaluated by PCR
amplification of a 620 bp portion of the gene with the for-
ward primer katG904 (5'-AGCTCGTATGGCACCGGAAC)
and the reverse primer katG1523 (5'-TTGACCTCCCAC-
CCGACTTG) [23], followed by digestion with MspI. In the
presence of the CGG variant of codon 463, a MspI recog-
nition site is formed, and the two alleles are easily differ-
entiated by their restriction patterns.
Polymorphism at codon 95 of the gyrA gene was detected
by PCR amplification of a 320 bp fragment using the
primers gyrA1 (5'-CAGCTACATCGACTATGCGA) and
gyrA2 (5'-GGGCTTCGGTGTACCTCAT) [24] followed by
DNA sequencing.
Information and statistical analysis of the patients
Medical and laboratory records of the patients were retro-
spectively and thoroughly reviewed. The primary routine
contact investigation reports of the TB surveillance system
in Zaragoza were also collected. The information included
demographic data (age, sex, country of origin, place of res-
idence), microbiological data (date of isolation and drug
sensitivity), clinical data (site of disease), risk factors for
TB (homelessness, injection drug use, alcohol and/or
tobacco abuse, presence of HIV infection and history of
previous imprisonment), and other information about
possible epidemiological links.
The characteristics of the 85 patients in the MTZ cluster
were compared with the other 369 TB patients studied in
2001–2004 [15]. We used the chi-square test (Yates-cor-
rected) or Fisher's exact test to compare categorical data.
Table 1: PCR mixtures and conditions used for the MIRU-VNTR genotyping
Multiplex Locus Alias VNTR length (bp) [MgCl2] (mM) PCR primer pairs (5' to 3'), with labelling indicated in bracketsa
Mix 1 580 MIRU 4 77 3 GCGCGAGAGCCCGAACTGC (FAM)
GCGCAGCAGAAACGCCAGC
2996 MIRU 26 51 3 TAGGTCTACCGTCGAAATCTGTGAC
CATAGGCGACCAGGCGAATAG (HEX)
802 MIRU 40 54 3 GGGTTGCTGGATGACAACGTGT (TAMRA)
GGGTGATCTCGGCGAAATCAGATA
Mix 2 960 MIRU 10 53 2 GTTCTTGACCAACTGCAGTCGTCC
GCCACCTTGGTGATCAGCTACCT (FAM)
1644 MIRU 16 53 2 TCGGTGATCGGGTCCAGTCCAAGTA
CCCGTCGTGCAGCCCTGGTAC (HEX)
3192 MIRU 31 53 2 ACTGATTGGCTTCATACGGCTTTA
GTGCCGACGTGGTCTTGAT (TAMRA)
Mix 3 424 Mtub04 51 1.5 CTTGGCCGGCATCAAGCGCATTATT
GGCAGCAGAGCCCGGGATTCTTC (FAM)
577 ETR C 58 1.5 CGAGAGTGGCAGTGGCGGTTATCT (HEX)
AATGACTTGAACGCGCAAATTGTGA
2165 ETR A 75 1.5 AAATCGGTCCCATCACCTTCTTAT (TAMRA) 
CGAAGCCTGGGGTGCCCGCGATTT
Mix 4 2401 Mtub30 58 3 CTTGAAGCCCCGGTCTCATCTGT (FAM)
ACTTGAACCCCCACGCCCATTAGTA
3690 Mtub39 58 3 CGGTGGAGGCGATGAACGTCTTC (HEX)
TAGAGCGGCACGGGGGAAAGCTTAG
4156 QUB-4156 59 3 TGACCACGGATTGCTCTAGT
GCCGGCGTCCATGTT (TAMRA)
Mix 5 2163
b
QUB-11b 69 1.5 CGTAAGGGGGATGCGGGAAATAGG
CGAAGTGAATGGTGGCAT (FAM)
1955 Mtub21 57 1.5 AGATCCCAGTTGTCGTCGTC (HEX)
CAACATCGCCTGGTTCTGTA
4052 QUB-26 111 1.5 AACGCTCAGCTGTCGGAT (TAMRA)
CGGCCGTGCCGGCCAGGTCCTTCCCGAT
a VIC and NED labeling used in reference 19 have been replaced by HEX (5'-hexachloro-fluorescein phosphoramidite) and TAMRA (6'-carboxy-
tetramethyl-rhodamine), respectively.BMC Pulmonary Medicine 2009, 9:3 http://www.biomedcentral.com/1471-2466/9/3
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The Mann-Whitney non-parametric test was used to com-
pare the distribution of age as a continuous variable. The
SPSS program for Windows (version 11.5; SPSS Inc, Chi-
cago Il) was used for statistical analyses.
Results and discussion
DNA fingerprinting
The 85 isolates of the MTZ cluster all showed the same
IS6110-RFLP pattern, Spoligotype pattern and MIRU-
VNTR pattern. The genetic profiles are shown in Figure 1.
RFLP detected ten copies of IS6110 in the MTZ strain; this
pattern was previously identified in only two patients
from Zaragoza in 1993 and 1995 [25,26] and did not
match any other profiles included in the database of the
University of Zaragoza. Thus it is likely that this strain
spread recently and was not endemic in our region during
the nineties.
M. tuberculosis MTZ strain was assigned to one of the three
PGG (22) trying to provide a better framework for phylo-
genetic of this M. tuberculosis strain. The SNPs in codon
KatG463 (CGG) and codon gyrA95 (AGC) revealed that
the MTZ strain belonged to the principal genetic group 3.
The MTZ spoligotyping profile did not belong to any of
the predominant spoligotype families from Spain, Europe
or any other region of the world and did not match highly
transmissible profiles like the W-Beijing [18]. The spoligo-
typing profile corresponded to the SIT number 773 in the
SpolDB4 database (octal number 777777760000031),
with no related genetic family identified and only five iso-
lates reported (four from New York City, USA, and one
from Jakarta, Indonesia) [18]. Further comparison with
the updated database did not show any new additions
since the last 5 strains described in SpolDB4. The search
for 12-loci MIRU pattern 223425153322 showed that it
belonged to a widely reported shared-type MIT157 in the
updated SITVIT2 database; it was shared by a total of 61
strains from 9 different settings: Croatia (20/61 or 33%),
Belgium (16/61 or 26%), Great Britain (11/61 or 18%),
Spain (3/61 or 5%), French overseas departments of the
Americas (Guadeloupe, Martinique, French Guiana; 5/61
or 8%), Sweden (2/61 or 3%), South Africa (2/61 or 3%),
USA (1/61 or 1.5%), and Italy (1/61 or 1.5%). Spoligo-
types were available for only 31/61 strains sharing
MIT157, with the following distribution of the genotypic
lineages: T lineage (25/31 or 80%), Haarlem (4/31 or
13%), LAM (1/31 or 3%), and Beijing (1/31 or 3%). The
signature of the SIT773 contained a very unusual absence
of spacers 37 to 40, which does not denote any known lin-
eage-specific signature in SpolDB4 or SITVIT2 databases.
The overall pattern of SIT773 has a resemblance to the
"Zero copy" lineage described previously (18), nonethe-
less, the fact that MIRU24 value is equal to "1" together
with the assignation at the group 3 of the PGG, suggest
that the MTZ strain might be an evolutionary "modern"
strain of tubercle bacilli. Further investigations using SNPs
and 24-loci MIRU-VNTR would be necessary to determine
the exact phylogeographical specificity of the strains con-
taining this SIT773 pattern.
The comparison to MIRU-VNTRplus web server http://
www.miru-vntrplus.org/ (21), and with MLVA database
in http://minisatellites.u-psud.fr/MLVAnet/, did not
report any new information.
The molecular typing of the 85 isolates by Spoligotyping
and MIRU-VNTR typing was also useful to confirm the
composition of the large MTZ cluster initially identified
by IS6110-RFLP.M. tuberculosis isolates from epidemiolog-
ically linked patients generally show identical IS6110-
RFLP patterns; however, IS6110-based RFLP fingerprints
are not always reliable indicators of epidemiological link-
age [27-29], and MIRU-VNTR typing can subdivide
IS6110-RFLP clusters with no epidemiological connec-
tions [19,30]. The epidemiological information on the
MTZ cases was limited, because the molecular typing was
retrospective and subsequent to the contact tracing and
the patients were not re-interviewed. Despite the absence
of epidemiological links (only small groups of patients,
constituting a total of 26 patients altogether, were clearly
linked) (Table 2), the MIRU typing did not separate the
cluster of 85 isolates, suggesting that all the patients stud-
ied could be connected.
IS6110-RFLP pattern, Spoligotyping pattern and MIRU-VNTR  profiles of the MTZ strain Figure 1
IS6110-RFLP pattern, Spoligotyping pattern and 
MIRU-VNTR profiles of the MTZ strain.
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Characteristics and epidemiological investigation of the 
patients
Sixty (70.6%) of the 85 cases of the MTZ cluster were men
and 25 (29.4%) were women. The median age of the
patients was 30 years (25th percentile [P25] to P75, 23 to
41) with a range of 8 months to 68 years. Seventy-three
(86%) patients were born in Spain; 12 (14%) were for-
eign-born. All patients presented with a drug-susceptible
isolate, except one patient with history of relapse and
non-adherence to the TB treatment, who presented a
rifampicin-resistant isolate.
We compared the characteristics of the MTZ-infected
patients with the rest of clustered patients from the previ-
ous study (154 cases) and with total patients studied
(clustered and non-clustered, 369 cases). The median age
of MTZ-infected patients was lower (30 years) than that of
other clustered patients (median age 38 years; P25 to P75,
29 to 46) or than that of all patients (median age 40 years;
P25 to P75, 30 to 62) (P < 0.001 in both comparisons).
Almost all (94.1%) of the MTZ-infected patients lived in
Zaragoza city; the corresponding values were 81.5% for
other clustered patients (P = 0.012) and 76.1% for all
patients (P < 0.001). The MTZ-infected patients were less
likely to be injection drug users (9.9%) than other clus-
tered patients (22.9%) (P = 0.024), and presented more
frequently with pulmonary TB than all other patients
(95.3% vs. 85.1%; P = 0.019). In many TB outbreaks, the
patients share a common risk factor for TB such as home-
lessness, HIV infection, injection drug abuse or alcohol
abuse [5-9,31]. However, in our study, MTZ  cluster
patients do not appear to be linked by any common char-
acteristic or risk factors for TB. Other European studies
have reported the dissemination of TB strains among low-
Table 2: Characteristics of epidemiologically linked patients of the MTZ cluster
ID n° Age (years) Sex Date of isolation HIV status Origin Epidemiological link Area of residencea
121 43 Man 200402 Negative Spain Family contact 10
130 38 Woman 200402 Negative Spain Children attending the same nursery 10
140 26 Woman 200404 Negative Spain Nursery staff b -
449 1 Man 200404 Unknown Spain Children attending the same nursery 1
443 2 Woman 200404 Unknown Spain Children attending the same nursery 3
437 1 Man 200404 Unknown Spain Children attending the same nursery 1
445 1 Man 200404 Unknown Spain Children attending the same nursery 2
148 2 Woman 200404 Unknown Spain Children attending the same nursery 1
441 2 Woman 200404 Unknown Spain Children attending the same nursery 2
444 1 Man 200404 Unknown Spain Children attending the same nursery 1
442 1 Woman 200404 Unknown Spain Children attending the same nursery 4
180 2 Woman 200108 Unknown Spain Family contact -
186 20 Woman 200109 Negative Spain 18b
159 35 Man 200106 Negative Spain -
269 26 Woman 200207 Negative Algeria Family contact 16
257 43 Man 200206 Negative Spain 16
272 51 Man 200208 Unknown Spain Family contact 18c
285 19 Man 200209 Negative Spain 18c
160 41 Man 200106 Negative Spain Family contact 18d
341 5 Man 200304 Unknown Spain 18d
201 27 Man 200111 Negative Spain Family contact 17
196 23 Woman 200110 Negative Spain 17
422 24 Woman 200402 Unknown Spain Family contact 7
419 8 months Woman 200402 Negative Spain 7
36 25 Man 200205 Positive Spain Friendship contact -
56 25 Man 200209 Unknown Spain -
a The areas of residence are shown in figure 2. The dash (-) means that the patient did not live in any of the 18 areas of residence (see figure 2). b 
The parents of the woman who worked at the nursery lived close to area n° 5. The woman also worked for 7 years in a bingo hall in area 18d, and 
for one year in a bingo hall between the areas 7 and 8.
n°: patient identification number.BMC Pulmonary Medicine 2009, 9:3 http://www.biomedcentral.com/1471-2466/9/3
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risk individuals, such as the Harlingen strain in the Neth-
erlands or the Danish cluster 2 strain in Denmark [12-14].
A number of epidemiological links could be established
from the data available from patient medical records and
contact investigation reports. Eight children (all between
one and two years old) and one nursery staff were linked
because they attended the same nursery [32]. Familial
links were identified involving 15 household contacts in
seven different families and a friendship link between two
other patients. Patient characteristics are detailed in Table
2.
A significant data was the proportion of patients linked by
place of residence. The study area included the province of
Zaragoza [15], which is composed of both urban and rural
areas, but 94.1% of the MTZ-infected patients lived in
Zaragoza city. Thirty-nine patients were linked into
groups of two or three individuals because they lived in
the same street, or in parallel, adjoining or perpendicular
streets (Table 3). Seventy-eight cases of the MTZ cluster
were situated in the city of Zaragoza, and 21 (25%) of
these were concentrated in the old town centre (Figure 2).
The other seven patients lived in peripheral districts or in
rural areas. Other studies have demonstrated that patients
whose residences are geographically aggregated may be
clustered [33] and therefore, the location of TB exposure
is an important factor to consider in addition to the con-
tact tracing [9,34,35]. TB transmission between sporadic
or casual contacts has been documented [29,31]; hypo-
Location of 78 cases of the MTZ cluster in Zaragoza City according to the place of residence Figure 2
Location of 78 cases of the MTZ cluster in Zaragoza City according to the place of residence. The cases grouped 
inside a circle lived in the same street, or in parallel, adjoining or perpendicular streets. The areas that included two or more 
cases are numbered from 1 to 18.
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Table 3: Characteristics of the MTZ cluster patients linked by the place of residence and/or by common risk factors for TB
ID n° Age (years) Sex Date of isolation HIV status Origin Area of Residence a Characteristics in common b
371 30 Man 200307 Negative Guinea 11 Neighbours
42 25 Man 200206 Negative Spain 11
177 32 Woman 200109 Negative Spain 18d Neighbours
171 38 Man 200108 Negative Spain 18d
60 44 Man 200209 Negative Spain - Prison, alcoholism
258 36 Man 200205 Positive Spain - Prison, alcoholism
167 47 Man 200107 Unknown Spain - Prison
246 33 Man 200204 Negative Spain 18b Neighbour of 322
322 27 Man 200303 Negative Egypt 18b Prison, neighbour of 246, IDU
69 24 Man 200211 Negative Unknown 18a Neighbours, alcoholism
263 53 Man 200207 Negative Spain 18a Neighbours, alcoholism
374 46 Man 200308 Positive Spain 18a Ex-IDU
217 34 Man 200112 Positive Unknown - Ex-IDU
23 36 Man 200112 Positive Spain - Ex-IDU
304 34 Man 200303 Negative South America - Ex-IDU
79 26 Man 200212 Positive Venezuela 6 -
434 56 Man 200403 Unknown Spain 6 Alcoholism. Worked next to area 
5
271 39 Man 200208 Negative Spain - Alcoholism
178 47 Man 200109 Negative Spain 3 Alcoholism
428 26 Woman 200402 Positive Spain 4 Lived in the same area than 442 
(table 2)
318 44 Man 200303 Negative Gambia - 15 years in Spain
312 25 Man 200302 Negative Gambia 10 10 years in Spain. Worked in area 
8.
59 39 Woman 200209 Negative Spain 8
76 43 Man 200212 Unknown Ukraine 8
125 60 Woman 200402 Negative Spain 8
302 41 Man 200301 Negative Spain 15
427 46 Man 200402 Negative Spain 15
94 50 Man 200307 Negative Spain 9
194 57 Man 200109 Negative Spain 9
209 31 Man 200112 Negative Spain 12
283 26 Man 200209 Negative Spain 12
174 36 Woman 200108 Negative Spain 13
205 26 Woman 200111 Negative Spain 13
342 21 Man 200305 Negative Spain 14
276 35 Man 200209 Negative Spain 14
237 49 Man 200204 Positive Spain 5
297 28 Man 200210 Negative Unknown 5
247 36 Woman 200205 Positive Spain 18a
199 63 Man 200111 Unknown Spain 18a
385 44 Man 200309 Positive Spain 18bBMC Pulmonary Medicine 2009, 9:3 http://www.biomedcentral.com/1471-2466/9/3
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thetically, the transmission of the MTZ strain could have
occurred casually in public settings, probably near to the
residences of patients.
In one of the small outbreaks caused by MTZ strain regis-
tered among children attending at a nursery, 11.7%
showed a positive skin test and 90.9% of them developed
the illness [32]. However, the percentage of infected chil-
dren was surprisingly low in view of the dissemination of
this strain among the total population in Zaragoza. Like
strains involved in other outbreaks, the MTZ strain might
have unique characteristics for virulence and/or transmis-
sibility [36-39]. The transmission of tuberculosis may
have been due to the increased virulence of the strain
rather than to environmental factors or patient character-
istics.
Another possible explanation for the extensive spread of
the MTZ strain could be that this strain was endemic in
our region, but in a previous molecular study performed
in the same area between 1993 and 1995 [25,26], MTZ
was only isolated from two Spanish patients who were not
apparently connected; one in 1993 and one in 1995. The
first patient was an 11 year-old girl living in a rural area,
and the second was a 22 year-old woman living in the old
town centre in Zaragoza. Surprisingly, both patients pre-
sented with rare extra-pulmonary locations of TB (bone
TB and intestinal TB respectively), whereas 95.3% of the
cases reported from 2001 to 2004 presented with pulmo-
nary TB. The period from 1995 to 2001 has not been stud-
ied, and it seems likely that more MTZ cases would be
identified during this period. A more detailed epidemio-
logical investigation of the outbreak is needed to elucidate
the chain of transmission.
Conclusion
In conclusion, neither the genetic profiles exhibited by the
MTZ strain nor the characteristics of the patients affected
could explain the reasons for the dominance and wide-
spread of this modern strain. The MTZ strain might have
particular transmissibility or virulence properties that
need to be studied, and we believe that greater focus
should be placed on stopping its widespread dissemina-
tion. Molecular typing has been a decisive tool to detect
this unsuspected TB outbreak, and demonstrates the
importance of the combination of both traditional
approaches and molecular epidemiology for TB surveil-
lance.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SS and AILC designed the study, supervised all the experi-
mental work, analyzed the results, wrote the manuscript.
AILC and PG performed the experimental assays. MALe
and MAV compiled all the isolates and the first clinical
and epidemiological data. JG, MALa collect all the clinical
and epidemiological data. MJI helped in analysis of
results. NR helped in the global analysis of the genotype.
CM and MJR critically reviewed the final version of the
manuscript. All authors read and approved the final man-
uscript.
Acknowledgements
This work was supported by Fondo de Investigaciones Sanitarias (FIS 06/
1624).
The authors thank Thierry Zozio (Pasteur Institute of Guadeloupe) for data 
comparison using the SITVIT2 database. Any inquiries regarding the 
SITVIT2 should be addressed to nrastogi@pasteur-guadeloupe.fr. The 
authors also would like to thank Carmen Lafoz, Daniel Ibarz, Ana Picó and 
Ana Belén Gómez for their excellent technical assistance and Alberto 
Cebollada for his help with the statistical analysis.
References
1. World Health Organization: Global tuberculosis control: sur-
veillance, planning, financing. WHO report 2007.  In (WHO/
HTM/TB/2007.376) Geneva, World Health Organization; 2007. 
2. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN: Molecular Epi-
demiology of Tuberculosis: Current Insights.  Clin Microbiol Rev
2006, 19:658-685.
3. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, Mog-
hazeh SL, Eisner W, Daniel TM, Kaplan MH, Crawford JT, Musser JM,
Kreiswirth BN: Origin and interstate spread of a New York
City multidrug-resistant Mycobacterium tuberculosis clone
family.  JAMA 1996, 275:452-457.
4. Bifani PJ, Mathema B, Liu Z, Moghazeh SL, Shopsin B, Tempalski B,
Driscol J, Frothingham R, Musser JM, Alcabes P, Kreiswirth BN: Iden-
tification of a W variant outbreak of Mycobacterium tubercu-
losis  via population-based molecular epidemiology.  JAMA
1999, 282:2321-2327.
5. Caminero JA, Pena MJ, Campos-Herrero MI, Rodríguez JC, García I,
Cabrera P, Lafoz C, Samper S, Takiff H, Afonso O, Pavón JM, Torres
MJ, van Soolingen D, Enarson DA, Martin C: Epidemiological evi-
18 68 Man 200111 Unknown Spain 18b
431 29 Woman 200402 Positive Spain 18c
214 53 Man 200201 Negative Spain 18c
370 52 Man 200308 Negative Spain 18c
26 31 Woman 200201 Negative Spain 18c
260 33 Man 200206 Negative Spain 18d
158 20 Woman 200106 Unknown Spain 18d
a The areas of residence are shown in figure 2. The dash (-) means that the patients did not live in any of the 18 areas of residence (see figure 2). b 
Patients were classified as "neighbours" when they lived in the same street.
ID n°: patient identification number. IDU: injection drug user.
Table 3: Characteristics of the MTZ cluster patients linked by the place of residence and/or by common risk factors for TB (Continued)BMC Pulmonary Medicine 2009, 9:3 http://www.biomedcentral.com/1471-2466/9/3
Page 9 of 10
(page number not for citation purposes)
dence of the spread of a Mycobacterium tuberculosis strain of
the Beijing genotype on Gran Canaria Island.  Am J Respir Crit
Care Med 2001, 164:1165-1170.
6. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U,
Zeller K, Andrews J, Friedland G: Extensively drug-resistant
tuberculosis as a cause of death in patients co-infected with
tuberculosis and HIV in a rural area of South Africa.  Lancet
2006, 368:1575-80.
7. Samper S, Martín C: Spread of extensively drug-resistant tuber-
culosis.  Emerg Infect Dis 2007, 13:647-8 [http://www.cdc.gov/eid/
content/13/4/647.htm].
8. Friedman CR, Quinn GC, Kreiswirth BN, Perlman DC, Salomon N,
Schluger N, Lutfey M, Berger J, Poltoratskaia N, Riley LW: Wide-
spread dissemination of a drug-susceptible strain of Myco-
bacterium tuberculosis.  J Infect Dis 1997, 176:478-84.
9. Macaraig M, Agerton T, Driver CR, Munsiff SS, Abdelwahab J, Park J,
Kreiswirth B, Driscoll J, Zhao B: Strain-specific differences in two
large  Mycobacterium tuberculosis genotype clusters in iso-
lates collected from homeless patients in New York City
from 2001 to 2004.  J Clin Microbiol 2006, 44:2890-6.
10. Rajakumar K, Shafi J, Smith RJ, Stabler RA, Andrew PW, Modha D,
Bryant G, Monk P, Hinds J, Butcher PD, Barer MR: Use of genome
level-informed PCR as a new investigational approach for
analysis of outbreak-associated Mycobacterium tuberculosis
isolates.  J Clin Microbiol 2004, 42:1890-6.
11. Watson JM, Moss F: TB in Leicester: out of control, or just one
of those things?  BMJ 2001, 322:1133-4.
12. Kiers A, Drost AP, van Soolingen D, Veen J: Use of DNA finger-
printing in international source case finding during a large
outbreak of tuberculosis in The Netherlands.  Int J Tuberc Lung
Dis 1997, 1:239-45.
13. van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Des-
sens M, Kremer K, van Embden JD: Molecular epidemiology of
tuberculosis in the Netherlands: a nationwide study from
1993 through 1997.  J Infect Dis 1999, 180:726-36.
14. Lillebaek T, Dirksen A, Kok-Jensen A, Andersen AB: A dominant
Mycobacterium tuberculosis strain emerging in Denmark.  Int
J Tuberc Lung Dis 2004, 8:1001-6.
15. López-Calleja AI, Lezcano MA, Vitoria MA, Iglesias MJ, Cebollada A,
Lafoz C, Gavin P, Aristimuño L, Revillo MJ, Martin C, Samper S: Gen-
otyping of Mycobacterium tuberculosis over two periods: a
changing scenario for tuberculosis transmission.  Int J Tuberc
Lung Dis 2007, 11:1080-6.
16. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gic-
quel B, Hermans P, Martin C, McAdam R, Shinnick TM, Small P:
Strain identification of Mycobacterium tuberculosis by DNA
fingerprinting: recommendations for a standardized meth-
odology.  J Clin Microbiol 1993, 31:406-409.
17. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D,
Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden
J: Simultaneous detection and strain differentiation of Myco-
bacterium tuberculosis for diagnosis and epidemiology.  J Clin
Microbiol 1997, 35:907-14.
18. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA,
Allix C, Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P,
Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux
M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes
HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kre-
iswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho
ML, Martin C, Martin C, Mokrousov I, Narvskaïa O, Ngeow YF, Nau-
mann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V,
Rasolonavalona T, Rossetti ML, Rüsch-Gerdes S, Sajduda A, Samper
S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen D,
Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC,
Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C: Myco-
bacterium tuberculosis complex genetic diversity: mining the
fourth international spoligotyping database (SpolDB4) for
classification, population genetics and epidemiology.  BMC
Microbiol 2006, 6:23.
19. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S,
Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P,
Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC,
Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D:
Proposal for standardization of optimized mycobacterial
interspersed repetitive unit-variable-number tandem repeat
typing of Mycobacterium tuberculosis.  J Clin Microbiol 2006,
44:4498-510.
20. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C:
Automated high-throughput genotyping for study of global
epidemiology of Mycobacterium tuberculosis based on myco-
bacterial interspersed repetitive units.  J Clin Microbiol 2001,
39:3563-71.
21. Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S: Eval-
uation and user-strategy of MIRU-VNTR plus, a multifunc-
tional database for online analysis of genotyping data and
phylogenetic identification of Mycobacterium  tuberculosis
complex isolates.  J Clin Microbiol 2008, 46:2692-9.
22. Sreevatsan S, Pan X, Stockbauer K, Connell N, Kreiswirth B, Whittam
T, Musser JM: Restricted structural gene polymorphism in the
Mycobacterium tuberculosis complex indicates evolutionarily
recent global dissemination.  Proc Natl Acad Sci USA 1997,
94:9869-9874.
23. Uhl JR, Sandhu GS, Kline BC, Cockerill FR III: PCR-RFLP detection
of point mutations in the catalase-peroxidase gene (katG) of
M. tuberculosis associated with isoniazid resistance.  In PCR
protocols for emerging infectious diseases Edited by: Persing DH. ASM
Press, Washington, D.C; 1996:144-149.
24. Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth
B, Cole ST, Jacobs WR Jr, Telenti A: Cloning and nucleotide
sequence of Mycobacterium tuberculosis gyrA and gyrB genes
and detection of quinolone resistance mutations.  Antimicrob
Agents Chemother 1994, 38:773-80.
25. Samper S, Iglesias MJ, Rabanaque MJ, Lezcano MA, Vitoria LA, Rubio
MC, Gómez-Lus R, Gómez LI, Otal I, Martín C: The molecular epi-
demiology of tuberculosis in Zaragoza, Spain: a retrospec-
tive epidemiological study in 1993.  Int J Tuberc Lung Dis 1998,
2:281-7.
26. Iglesias MJ: Molecular epidemiology of tuberculosis in
Zaragoza 1993–1995.  In Ph.D. Thesis U n i v e r s i t y  o f  Z a r a g o z a ,
Zaragoza, Spain; 1998. 
27. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, Castro
KG, Moers D, Yang Z, Stead WW, Bates JH: Interpretation of
restriction fragment length polymorphism analysis of Myco-
bacterium tuberculosis isolates from a state with a large rural
population.  J Infect Dis 1997, 175:1446-52.
28. Gillespie SH, Dickens A, McHugh TD: False molecular clusters
due to nonrandom association of IS6110 with Mycobacterium
tuberculosis.  J Clin Microbiol 2000, 38:2081-6.
29. van Deutekom H, Hoijng SP, de Haas PE, Langendam MW, Horsman
A, van Soolingen D, Coutinho RA: Clustered tuberculosis cases:
do they represent recent transmission and can they be
detected earlier?  Am J Respir Crit Care Med 2004, 169:806-10.
30. van Deutekom H, Supply P, de Haas PE, Willery E, Hoijng SP, Locht
C, Coutinho RA, van Soolingen D: Molecular typing of Mycobac-
terium tuberculosis by mycobacterial interspersed repetitive
unit-variable-number tandem repeat analysis, a more accu-
rate method for identifying epidemiological links between
patients with tuberculosis.  J Clin Microbiol 2005, 43:4473-9.
31. Diel R, Meywald-Walter K, Gottschalk R, Rüsch-Gerdes S, Niemann
S: Ongoing outbreak of tuberculosis in a low-incidence com-
munity: a molecular-epidemiological evaluation.  Int J Tuberc
Lung Dis 2004, 8:855-61.
32. Sarrat Torres R, Macipe Costa R, de Juan Martín F, Lezcano Carreras
MA, Bouthelier Moreno M, Marín Bravo MC, Esteban Ibarz JA: Epi-
demic outbreak of tuberculosis in a daycare centre in
Zaragoza (Spain).  An Pediatr (Barc) 2006, 65:219-24.
33. Bishai WR, Graham NM, Harrington S, Pope DS, Hooper N, Astem-
borski J, Sheely L, Vlahov D, Glass GE, Chaisson RE: Molecular and
geographic patterns of tuberculosis transmission after 15
years of directly observed therapy.  JAMA 1998, 280:1679-84.
34. Barnes PF, el-Hajj H, Preston-Martin S, Cave MD, Jones BE, Otaya M,
Pogoda J, Eisenach KD: Transmission of tuberculosis among the
urban homeless.  JAMA 1996, 275:305-307.
35. Barnes PF, Yang Z, Preston-Martin S, Pogoda JM, Jones BE, Otaya M,
Eisenach KD, Knowles L, Harvey S, Cave MD: Patterns of tubercu-
losis transmission in Central Los Angeles.  JAMA 1997,
278:1159-63.
36. Beggs ML, Eisenach KD, Cave MD: Mapping of IS6110 insertion
sites in two epidemic strains of Mycobacterium tuberculosis.  J
Clin Microbiol 2000, 38:2923-8.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pulmonary Medicine 2009, 9:3 http://www.biomedcentral.com/1471-2466/9/3
Page 10 of 10
(page number not for citation purposes)
37. Perez E, Samper S, Bordas Y, Guilhot C, Gicquel B, Martin C: An
essential role for phoP in Mycobacterium tuberculosis viru-
lence.  Mol Microbiol 2001, 41:179-87.
38. Soto CY, Menéndez MC, Pérez E, Samper S, Gómez AB, García MJ,
Martín C: IS6110 mediates increased transcription of the phoP
virulence gene in a multidrug-resistant clinical isolate
responsible for tuberculosis outbreaks.  J Clin Microbiol 2004,
42:212-9.
39. Valway SE, Sanchez MP, Shinnick TF, Orme I, Agerton T, Hoy D, Jones
JS, Westmoreland H, Onorato IM: An outbreak involving exten-
sive transmission of a virulent strain of Mycobacterium tuber-
culosis.  N Engl J Med 1998, 338:633-9.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2466/9/3/prepub